Literature DB >> 18494739

Retinal circulatory disturbances following intracameral injection of bevacizumab for neovascular glaucoma.

Katsuhiko Yokoyama, Toshiharu Choshi, Kenichi Kimoto, Kei Shinoda, Kazuo Nakatsuka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18494739     DOI： 10.1111/j.1755-3768.2008.01187.x

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN： 1755-375X            Impact factor:   3.761


× No keyword cloud information.
  16 in total

1.  Adverse events associated with intraocular injections of bevacizumab in eyes with neovascular glaucoma.

Authors:  Tomomi Higashide; Eiji Murotani; Yoshiaki Saito; Shinji Ohkubo; Kazuhisa Sugiyama
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2011-11-25       Impact factor: 3.117

2.  Panretinal photocoagulation with simultaneous cryoretinopexy or intravitreal bevacizumab for neovascular glaucoma.

Authors:  Tomoaki Tatsumi; Shuichi Yamamoto; Juntaro Uehara; Takeshi Sugawara; Takayuki Baba; Masayuki Inoue; Hiroko Hata; Yoshinori Mitamura
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-12-19       Impact factor: 3.117

3.  Intravitreal anti-VEGF agents, oral glucocorticoids, and laser photocoagulation combination therapy for macular edema secondary to retinal vein occlusion: preliminary report.

Authors:  Xiao-Xiao Feng; Cheng Li; Wan-Wen Shao; Yong-Guang Yuan; Xiao-Bing Qian; Qi-Shan Zheng; Yu-Jie Li; Qian-Ying Gao
Journal:  Int J Ophthalmol       Date:  2018-03-18       Impact factor: 1.779

Review 4.  [Antiangiogenic treatment for neovascular glaucoma and after filtering surgery].

Authors:  J Lüke; M Lüke; S Grisanti
Journal:  Ophthalmologe       Date:  2009-05       Impact factor: 1.059

5.  Quantifying the increasing use of anti-vascular endothelial growth factor therapy in ophthalmology.

Authors:  Jonathan A Micieli; Andrew Micieli
Journal:  Mcgill J Med       Date:  2011-06

6.  Insight into 144 patients with ocular vascular events during VEGF antagonist injections.

Authors:  Ahmad M Mansour; Maha Shahin; Peter K Kofoed; Maurizio B Parodi; Michel Shami; Stephen G Schwartz
Journal:  Clin Ophthalmol       Date:  2012-03-06

7.  Choroidal thickness after intravitreal ranibizumab injections for choroidal neovascularization.

Authors:  Abdallah A Ellabban; Akitaka Tsujikawa; Ken Ogino; Sotaro Ooto; Kenji Yamashiro; Akio Oishi; Nagahisa Yoshimura
Journal:  Clin Ophthalmol       Date:  2012-05-30

8.  An experimental study of VEGF induced changes in vasoactivity in pig retinal arterioles and the influence of an anti-VEGF agent.

Authors:  Er-Ning Su; Stephen J Cringle; Ian L McAllister; Dao-Yi Yu
Journal:  BMC Ophthalmol       Date:  2012-05-29       Impact factor: 2.209

9.  Retinal ganglion cell function after repeated intravitreal injections of ranibizumab in patients with age-related macular degeneration.

Authors:  Tomoharu Nishimura; Shigeki Machida; Tomomi Harada; Daijiro Kurosaka
Journal:  Clin Ophthalmol       Date:  2012-07-13

10.  Changes in the foveal microstructure after intravitreal bevacizumab application in patients with retinal vascular disease.

Authors:  Nikolaus Feucht; Etienne Michael Schönbach; Ines Lanzl; Konstantin Kotliar; Chris Patrick Lohmann; Mathias Maier
Journal:  Clin Ophthalmol       Date:  2013-01-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.